KATIE FRANK: Open Payments
NPI 1518509561 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 9 payments from 6 companies in 2025. Trend: 2023 $123 · 2024 $263 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 4 | $104 |
| Cycle Pharmaceuticals Inc | 1 | $30 |
| BioCryst US Sales Co., LLC | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Haegarda, Sajazir, ORLADEYO, NEFFY, FASENRA.
Industry payments across FL — which companies pay providers there.
